Deepan Dalal, MD
Rheumatology · Cranston, RINPI 1962720441
Payments from drug & device makers
Across 824 payments — averaging $148.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$68K
- AbbVie$15K
- Boehringer Ingelheim$9K
- Janssen Scientific Affairs, LLC$8K
- Amgen$8K
- Pfizer$4K
- plus $9K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 146 | $68,494 |
| AbbVie | 144 | $14,846 |
| Boehringer Ingelheim | 11 | $8,923 |
| Janssen Scientific Affairs, LLC | 13 | $8,148 |
| Amgen(2 entities) | 131 | $7,718 |
| Pfizer | 47 | $4,493 |
| Merck | 6 | $2,900 |
| UCB, Inc. | 95 | $1,751 |
| AstraZeneca | 60 | $1,450 |
| GSK | 50 | $654 |
| Mallinckrodt Hospital Products Inc. | 23 | $631 |
| Sobi, Inc | 18 | $353 |
| Genentech USA, Inc. | 12 | $313 |
| Lilly USA, LLC | 13 | $243 |
| Sanofi | 8 | $173 |
| Organon | 10 | $165 |
| Novartis | 6 | $132 |
| Fresenius Kabi USA, LLC | 6 | $118 |
| E.r. Squibb & Sons, L.L.C. | 5 | $100 |
| ANI Pharmaceuticals, Inc. | 3 | $89 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $58 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $43 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Invivyd Inc | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $18 |
| Sandoz | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$122,037 in reported general payments places this provider in the 90th percentile of 22 rheumatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Cranston
- Jack MouradCranston$4K
- Matthew WhiteCranston$306
- Edward ReardonWarwick$403K
- Jay ToderJohnston$139K
- Anthony ReginatoE. Providence$109K
- David KadmonLincoln$13K
- Christopher D ArcyWesterly$7K
- Vinit Joseph GilvazPawtucket$4K
- Wendy SilversmithWesterly$3K
- Edward LallyE. Providence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.